505 related articles for article (PubMed ID: 9136925)
21. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano M; Hannon GJ; Beach D
Nature; 1993 Dec; 366(6456):704-7. PubMed ID: 8259215
[TBL] [Abstract][Full Text] [Related]
22. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
Phelps DE; Xiong Y
Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
[TBL] [Abstract][Full Text] [Related]
23. Ubiquitination of free cyclin D1 is independent of phosphorylation on threonine 286.
Germain D; Russell A; Thompson A; Hendley J
J Biol Chem; 2000 Apr; 275(16):12074-9. PubMed ID: 10766840
[TBL] [Abstract][Full Text] [Related]
24. Cyclic AMP negatively controls c-myc transcription and G1 cell cycle progression in p210 BCR-ABL transformed cells: inhibitory activity exerted through cyclin D1 and cdk4.
Williamson EA; Burgess GS; Eder P; Litz-Jackson S; Boswell HS
Leukemia; 1997 Jan; 11(1):73-85. PubMed ID: 9001421
[TBL] [Abstract][Full Text] [Related]
25. Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage.
Agami R; Bernards R
Cell; 2000 Jul; 102(1):55-66. PubMed ID: 10929713
[TBL] [Abstract][Full Text] [Related]
26. Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product.
Parry D; Bates S; Mann DJ; Peters G
EMBO J; 1995 Feb; 14(3):503-11. PubMed ID: 7859739
[TBL] [Abstract][Full Text] [Related]
27. Increased G1 cyclin/cdk activity in cells overexpressing the candidate oncogene, MCT-1.
Dierov J; Prosniak M; Gallia G; Gartenhaus RB
J Cell Biochem; 1999 Sep; 74(4):544-50. PubMed ID: 10440924
[TBL] [Abstract][Full Text] [Related]
28. Glucose-regulated stresses cause decreased expression of cyclin D1 and hypophosphorylation of retinoblastoma protein in human cancer cells.
Tomida A; Suzuki H; Kim HD; Tsuruo T
Oncogene; 1996 Dec; 13(12):2699-705. PubMed ID: 9000144
[TBL] [Abstract][Full Text] [Related]
29. Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination.
Sheaff RJ; Singer JD; Swanger J; Smitherman M; Roberts JM; Clurman BE
Mol Cell; 2000 Feb; 5(2):403-10. PubMed ID: 10882081
[TBL] [Abstract][Full Text] [Related]
30. Interaction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the proteasome.
Kiernan RE; Emiliani S; Nakayama K; Castro A; Labbé JC; Lorca T; Nakayama Ki K; Benkirane M
Mol Cell Biol; 2001 Dec; 21(23):7956-70. PubMed ID: 11689688
[TBL] [Abstract][Full Text] [Related]
31. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb.
Ezhevsky SA; Nagahara H; Vocero-Akbani AM; Gius DR; Wei MC; Dowdy SF
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10699-704. PubMed ID: 9380698
[TBL] [Abstract][Full Text] [Related]
32. The cyclin D1-dependent kinase associates with the pre-replication complex and modulates RB.MCM7 binding.
Gladden AB; Diehl JA
J Biol Chem; 2003 Mar; 278(11):9754-60. PubMed ID: 12519773
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
[TBL] [Abstract][Full Text] [Related]
34. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells.
Mann DJ; Higgins T; Jones NC; Rozengurt E
Oncogene; 1997 Apr; 14(15):1759-66. PubMed ID: 9150381
[TBL] [Abstract][Full Text] [Related]
35. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein.
Zhu X; Ohtsubo M; Böhmer RM; Roberts JM; Assoian RK
J Cell Biol; 1996 Apr; 133(2):391-403. PubMed ID: 8609171
[TBL] [Abstract][Full Text] [Related]
36. CDK4/cyclin D1/PCNA complexes during staurosporine-induced G1 arrest and G0 arrest of human fibroblasts.
Gadbois DM; Peterson S; Bradbury EM; Lehnert BE
Exp Cell Res; 1995 Sep; 220(1):220-5. PubMed ID: 7664838
[TBL] [Abstract][Full Text] [Related]
37. Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation.
Watts CK; Brady A; Sarcevic B; deFazio A; Musgrove EA; Sutherland RL
Mol Endocrinol; 1995 Dec; 9(12):1804-13. PubMed ID: 8614416
[TBL] [Abstract][Full Text] [Related]
38. Human cyclin C protein is stabilized by its associated kinase cdk8, independently of its catalytic activity.
Barette C; Jariel-Encontre I; Piechaczyk M; Piette J
Oncogene; 2001 Feb; 20(5):551-62. PubMed ID: 11313987
[TBL] [Abstract][Full Text] [Related]
39. Hyposmotic stress induces cell growth arrest via proteasome activation and cyclin/cyclin-dependent kinase degradation.
Tao GZ; Rott LS; Lowe AW; Omary MB
J Biol Chem; 2002 May; 277(22):19295-303. PubMed ID: 11897780
[TBL] [Abstract][Full Text] [Related]
40. Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase.
Kato JY; Matsuoka M; Strom DK; Sherr CJ
Mol Cell Biol; 1994 Apr; 14(4):2713-21. PubMed ID: 8139570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
